C-MYC as a key effector of WNT, PI3K/AKT, MAPK, and TGF-β signaling pathways in regulation of epithelial-mesenchymal transition during tumor metastasis. [PDF]
Moghbeli M.
europepmc +1 more source
A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 Medulloblastoma. [PDF]
Friske JD +18 more
europepmc +1 more source
ARNT2 repression disrupts neuronal identity and promotes glioblastoma growth. [PDF]
Hao YH +10 more
europepmc +1 more source
OGT-Mediated O-GlcNAcylation Stabilizes c-Myc Activity and Promotes Chemoresistance in Triple-Negative Breast Cancer. [PDF]
Li J, Zhang J.
europepmc +1 more source
MYC-driven TRIM27 upregulation promotes prostate cancer progression by enhancing CANX ubiquitination and activating PI3K/AKT signaling. [PDF]
Wang Z, Ning J, Xu L, Cheng F.
europepmc +1 more source
CNOT2 /c-Myc/STAT3 signaling is critically involved in glycolysis mediated apoptosis of benzyl isothiocyanate in hepatocellular carcinoma. [PDF]
Koh W, Park SY, Kim B, Shim BS, Kim SH.
europepmc +1 more source
Targeting the MYCN interaction network in neuroblastoma. [PDF]
Yow CX, Yeoh S, Leen E, Bayliss R.
europepmc +1 more source
c-Myc transactivates CFL1 to induce senescence-like phenotype and potentiate the bystander effects for the migration and proliferation in lung cancer cells. [PDF]
Chou YT +8 more
europepmc +1 more source
POM121 O-GlcNAcylation facilitates bone metastasis in non-small cell lung cancer through enhanced c-MYC nuclear import and ECM reprogramming. [PDF]
Ren YZ +5 more
europepmc +1 more source
Multi-target Mechanisms and Clinical Evidence for Ganzaoning Granule in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. [PDF]
Zhao H.
europepmc +1 more source

